EB- Semaglutide

Semaglutide, 10mg/ml

Semaglutide is a peptide drug, specifically a GLP-1 receptor agonist, approved for treating type 2 diabetes and obesity. It mimics the action of the natural hormone GLP-1, stimulating insulin release, reducing blood glucose levels, and decreasing body weight.

Semaglutide is a long-acting analog of the hormone glucagon-like peptide-1 (GLP-1). It binds to GLP-1 receptors in the pancreas, leading to increased insulin secretion, reduced glucagon release, and ultimately lower blood sugar. It also slows gastric emptying and increases satiety, contributing to weight loss.

Semaglutides aid in long-term weight management for adults with obesity or who are overweight with other health conditions.